The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Open accessAbstract
Background & aims Several case series have reported the effects of fecal microbiota transplantation (FMT) for ulcerative colitis (UC). We assessed the efficacy and safety of FMT for patients with UC in a double-blind randomized trial.Methods Patients with mild to moderately active UC (n = 50) were assigned to groups that underwent FMT with feces from healthy donors or were given autologous fecal microbiota (control); each transplant was administered via nasoduodenal tube at the start of the study and 3 weeks later. The study was performed at the Academic Medical Center in Amsterdam from June 2011 through May 2014. The composite primary end point was clinical remission (simple clinical colitis activity index scores ≤2) combined with ≥1-point decrease in the Mayo endoscopic score at week 12. Secondary end points were safety and microbiota composition by phylogenetic microarray in fecal samples.Results Thirty-seven patients completed the primary end point assessment. In the intention-to-treat analysis, 7 of 23 patients who received fecal transplants from healthy donors (30.4%) and 5 of 25 controls (20.0%) achieved the primary end point (P = .51). In the per-protocol analysis, 7 of 17 patients who received fecal transplants from healthy donors (41.2%) and 5 of 20 controls (25.0%) achieved the primary end point (P = .29). Serious adverse events occurred in 4 patients (2 in the FMT group), but these were not considered to be related to the FMT. At 12 weeks, the microbiota of responders in the FMT group was similar to that of their healthy donors; remission was associated with proportions of Clostridium clusters IV and XIVa.Conclusions In this phase 2 trial, there was no statistically significant difference in clinical and endoscopic remission between patients with UC who received fecal transplants from healthy donors and those who received their own fecal microbiota, which may be due to limited numbers. However, the microbiota of responders had distinct features from that of nonresponders, warranting further study. ClinicalTrials.gov Number: NCT01650038.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, in two randomized controlled trials of UC patients, FMT responders showed a higher similarity to their donors than nonresponders. 61,62”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [61]
In the citing paper
“One trial, in which two faecal transplants were given via the upper GI route, showed no difference in clinical or endoscopic remission between the faecal transplant group and the control group (given autologous stool).76”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Since that meta-analysis, two randomised controlled trials in UC show discrepant results.”
From The gut microbiota and host health: a new clinical frontier (2016) · cites this paper as [76]
In the citing paper
“Remission (full Mayo score <3 and complete mucosal healing) was achieved in 24% of patients after FMT and 5% with placebo; stool from patients receiving FMT had greater microbial diversity than that of patients given placebo.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“In the study by Moayyedi et. al, seventy-five patients with active UC were randomized to a weekly FMT or water enema for 6 weeks, and there was a statistically significant difference in remission, the primary outcome, between the two groups.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [77]
In the citing paper
“However, some researchers did not find significant differences in the efficacy of FMT, which may be related to the number and cycle of enemas, preparation process, and limited numbers (147, 148).”
From Stress triggers flare of inflammatory bowel disease in children and adults (2019) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Rutgeerts, P. J., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A. D., Johanns, J., Travers, S., Rachmilewitz, D., Hanauer, S. B., Lichtenstein, G. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050516 · Cited by 3,910
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Self-citationCoated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Schroeder, K. W., Tremaine, W. J., & Ilstrup, D. M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712243172603 · Cited by 3,037
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
Self-citationVedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P. J., Sands, B. E., Hanauer, S. B., Colombel, J., Sandborn, W. J., Assche, G. V., Axler, J. L., Kim, H. J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,892
Classification of Inflammatory Bowel Disease
Lennard‐Jones, J. E. (1989) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528909091339 · Cited by 2,022
Canoco Reference Manual and User’s Guide: Software for Ordination (version 5.0)
ter Braak, C. J. F., & Šmilauer, P. (2012) · Cited by 1,898
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Kostic, A. D., Xavier, R. J., & Gevers, D. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.009 · Cited by 1,789
Claesson, M. J., O’Sullivan, Ó., Wang, Q., Nikkilä, J., Marchesi, J. R., Smidt, H., de Vos, W. M., Ross, R. P., & O’Toole, P. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006669 · Cited by 900
Cited by
Sorted by citations
Items 601–700 of 922
Lauko, S., Gancarčíková, S., Hrčková, G., Hajdučková, V., Andrejčáková, Z., Fecskeová, L. K., Bertková, I., Hijová, E., Kamlárová, A., Janíčko, M., et al. (2023) · Biomedicines · doi:10.3390/biomedicines12010043 · Cited by 10
Laperrousaz, B., Levast, B., Fontaine, M., Nancey, S., Déchelotte, P., Dore, J. M., & Lehert, P. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03487-2 · Cited by 10
The gut immune axis in ulcerative colitis: insights from microbiome research
Wasim, R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11124-8 · Cited by 10
Liu, Y., Ji, X., Huang, Y., Li, Q., Ding, X. L., Wang, Y., Zhang, S., Wen, Q., Cui, B., Lü, X., et al. (2023) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2023.2185476 · Cited by 10
Marsool, M. D. M., Vora, N., Marsool, A. D. M., Pati, S., Narreddy, M., Patel, P., Gadam, S., & Prajjwal, P. (2023) · Disease-a-Month · doi:10.1016/j.disamonth.2023.101606 · Cited by 10
Medical Therapy of Active Ulcerative Colitis
Bürger, M., Schmidt, C., Teich, N., & Stallmach, A. (2015) · Visceral Medicine · doi:10.1159/000436959 · Cited by 10
The Microbiome: a Key Player in Human Health and Disease
Blum, H. E. (2017) · Journal of Healthcare Communications · doi:10.4172/2472-1654.100062 · Cited by 10
Chande, N., Costello, S. P., Limketkai, B. N., Parker, C. E., Nguyen, T. M., MacDonald, J. K., & Feagan, B. G. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz223 · Cited by 10
Adhesion Ileus after Fecal Microbiota Transplantation in Long-Standing Radiation Colitis
Harsch, I. A., & Konturek, P. C. (2019) · Case Reports in Gastrointestinal Medicine · doi:10.1155/2019/2543808 · Cited by 10
Merrick, B., Robinson, E. J., Bunce, C., Allen, L., Bisnauthsing, K. N., Izundu, C. C., Bell, J. T., Amos, G. C. A., Shankar‐Hari, M., Goodman, A. L., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038847 · Cited by 10
Fecal Microbiota Transplantation for Ulcerative Colitis. Are We Ready for Primetime?
Cheng, Y., & Fischer, M. (2020) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2020.08.006 · Cited by 10
Mcilroy, J. R., Nalagatla, N., Hansen, R., Hart, A. L., & Hold, G. L. (2018) · Frontline Gastroenterology · doi:10.1136/flgastro-2017-100936 · Cited by 10
UegWeek 2020 Poster Presentations
de Pierola, L. B. F., Nyssen, O. P., Cosme, Á., Bordin, D. S., Tepeš, B., Aísa, Á. P., Vaira, D., Álvarez, M. C., Fernández, M. C., Lerang, F., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620927345 · Cited by 10
Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease
Houshyar, Y., Zhang, F., Tavakoli, P., Grimm, M. C., & Hold, G. L. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2653288 · Cited by 9
Huang, B., An, H., Qiu, Y., Ye, T., Huang, Y., Zheng, M., Shi, D., Su, Y., & Wang, R. (2026) · Advances in Therapy · doi:10.1007/s12325-025-03431-0 · Cited by 9
Nanjing Consensus II on Washed Microbiota Transplantation: Statements From the CHINAGUT Conference
Zhang, F., Wong, H. S., Lu, G., Pi, Z., Zhang, T., Yu, H. H., Bu, N., Chen, X., Cui, B., Dafa, D., et al. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70006 · Cited by 9
Wang, K., Miao, Z., Dong, Y., & Ye, B. (2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.02.10 · Cited by 9
Chen, C., Chen, L., Sun, D., Li, C., Xi, S., Ding, S., Luo, R., Geng, Y., & Bai, Y. (2022) · Gut Pathogens · doi:10.1186/s13099-022-00491-3 · Cited by 9
Li, H., Li, Y., & Qian, J. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002704 · Cited by 9
Correlating the Gut Microbiome to Health and Disease
Marques, T. M., Mall, J. G., Forsgård, R. A., Wall, R., Brummer, R. J., & de Vos, W. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00010-2 · Cited by 9
Effects of fecal microbiota transplantation on metabolic health of DBA mice
Ye, W., Fan, J., Wu, W., Chen, Z., Huang, Q., & Qian, L. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1352555 · Cited by 9
Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional Foods
Vitetta, L., Oldfield, D., & Sali, A. (2024) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1602013 · Cited by 9
Current and future microbiome-based therapies in inflammatory bowel disease
Montrose, J. A., Kurada, S. V., & Fischer, M. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001027 · Cited by 9
Khajah, M. A. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1347812 · Cited by 9
Prospects of Using Microbiota Correction Methods in the Treatment of Inflammatory Bowel Disease
Akinshina, A. I., Smirnova, D. V., Zagaynova, A. V., Makarov, V. V., & Yudin, S. M. (2019) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2019-29-2-12-22 · Cited by 9
Huang, Y., Pan, P., Echeveste, C. E., Wang, H., Oshima, K., Lin, C., Yearsley, M., Xiao, J., Chen, J., Sun, C., et al. (2020) · Food Frontiers · doi:10.1002/fft2.34 · Cited by 9
Probiotics and fecal microbiota transplantation in surgical disorders
Yeh, A., & Morowitz, M. J. (2017) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2017.09.007 · Cited by 9
Recent Research on Fecal Microbiota Transplantation in Inflammatory Bowel Disease Patients.
Fischer, M. (2019) · Europe PMC (PubMed Central) · Cited by 9
Gut microbiome transfer—Finding the perfect fit
Leong, K. S. W., O'Sullivan, J. M., Derraik, J. G. B., & Cutfield, W. S. (2020) · Clinical Endocrinology · doi:10.1111/cen.14183 · Cited by 9
What’s New and What’s Next in Fecal Microbiota Transplantation?
Baydoun, H., Hussain, N., Wu, K., Kelly, C. R., & Fischer, M. (2025) · Biologics · doi:10.2147/btt.s486372 · Cited by 8
Popov, J., Caputi, V., Nandeesha, N., Rodriguez, D. A., & Pai, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111365 · Cited by 12
In inflammatory bowel disease and extraintestinal manifestations: What role does microbiome play?
Shen, Y., Zhu, H., Zhou, L., Zheng, Y.-Q., Zhang, Z., Xie, Y., Liu, Z., Peng, C., Wang, L., Zhao, C., et al. (2023) · Engineered Regeneration · doi:10.1016/j.engreg.2023.04.005 · Cited by 8
Lopetuso, L. R., Laterza, L., Petito, V., Pecere, S., Quaranta, G., CHIERICO, F. D., Puca, P., Schiavoni, E., Napolitano, D., Poscia, A., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11102536 · Cited by 8
Bosch, B., Hartikainen, A. K., Ronkainen, A., Scheperjans, F., Arkkila, P. E. T., & Satokari, R. M. (2023) · Microorganisms · doi:10.3390/microorganisms11122901 · Cited by 8
Tsukimi, T., Obana, N., Shigemori, S., Arakawa, K., Miyauchi, E., Yang, J., Song, I., Ashino, Y., Wakayama, M., Soga, T., et al. (2024) · mSystems · doi:10.1128/msystems.01123-23 · Cited by 8
Moutsoglou, D., Syal, A., Lopez, S., Nelson, E. C., Chen, L., Kabage, A. J., Fischer, M., Khoruts, A., Vaughn, B. P., & Staley, C. M. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae142 · Cited by 8
Fecal microbiota transplant via colonoscopy may be preferred due to intraprocedure findings
Cho, J. M., Pestana, L., Pardi, R. M., Pardi, D. S., & Khanna, S. (2019) · Intestinal Research · doi:10.5217/ir.2019.00056 · Cited by 8
Update on Fecal Microbiota Transplantation in Patients With Inflammatory Bowel Disease.
Moayyedi, P. (2018) · Europe PMC (PubMed Central) · Cited by 8
Mist1 promoted inflammation in colitis model via K+-ATPase NLRP3 inflammasome by SNAI1
Wang, T., Liu, W., Li, C., Si, G., Liang, Z., & Yin, J. (2021) · Pathology - Research and Practice · doi:10.1016/j.prp.2021.153511 · Cited by 8
Seth, A. K., & Jain, P. (2022) · Intestinal Research · doi:10.5217/ir.2021.00069 · Cited by 8
Facciotti, F. (2022) · PharmaNutrition · doi:10.1016/j.phanu.2022.100303 · Cited by 8
Etiology of Ulcerative Colitis
Preda, C.-M., & Istrătescu, D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106842 · Cited by 10
Yao, J., Fekadu, G., Ng, S. C., & You, J. H. S. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16015 · Cited by 8
Fecal Microbiota Transplantation Research over the Past Decade: Current Status and Trends
Hao, S., Yang, S., Zhang, N., & Cheng, H.-J. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/6981721 · Cited by 8
Hartikainen, A. K., Khan, I., Karjalainen, E. K., Renkonen‐Sinisalo, L., Arkkila, P., Jalanka, J., Lepistö, A., & Satokari, R. M. (2024) · Gut Microbes · doi:10.1080/19490976.2023.2295445 · Cited by 8
Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease
Kerman, D. H. (2016) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2016.06.006 · Cited by 8
Wang, H., Liu, S.-P., Ma, T., Yan, W., Zhou, J.-F., Shi, Y., Shen, P., Yang, X., & Wu, S.-N. (2018) · Medicine · doi:10.1097/md.0000000000010675 · Cited by 8
Holster, S., Hooiveld, G. J. E. J., Repsilber, D., de Vos, W. M., Brummer, R. J., & König, J. (2019) · Biomolecules · doi:10.3390/biom9100586 · Cited by 8
Tungland, B. C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814649-1.00009-0 · Cited by 8
Emerging Noninfectious Indications for Live Biotherapeutic Products in Gastroenterology
Newman, K. L., & Allegretti, J. R. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002584 · Cited by 7
Newman, K. L., Standke, A. K., James, G., Vendrov, K. C., Inohara, N., Bergin, I. L., Higgins, P., Rao, K., Young, V. B., & Kamada, N. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2604875 · Cited by 7
Xu, X., Fang, H., Fang, L., Zhou, Y., Wen, Y., Wang, X., Du, D., Lu, L., Yin, J., Sun, T., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.157829 · Cited by 7
Fecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and Beyond
Borody, T. J., Peattie, D. A., & Mitchell, S. (2015) · Antibiotics · doi:10.3390/antibiotics4030254 · Cited by 7
Patel, K., Patel, A. B., Hawes, D., Shah, J., & Shah, K. (2018) · Gastroenterology and hepatology from bed to bench. · Cited by 7
Wang, M., Xie, X., Zhao, S., Han, W., & Zhang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.990800 · Cited by 7
Dogra, S., Oneto, C., Sherman, A., Varughese, R., Yuen, A., Sherman, I., Cohen, A., Luo, Y., & Chen, L. A. (2022) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001778 · Cited by 7
Brüssow, H. (2023) · Microbiome Research Reports · doi:10.20517/mrr.2022.20 · Cited by 7
Buret, A. G. (2016) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2016.11 · Cited by 7
Classification and Reclassification of Inflammatory Bowel Diseases
Chang, S., & Shen, B. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811388-2.00002-6 · Cited by 7
Kim, M., Chung, S., Yang, J.-C., Park, J., Nam, S. H., & Park, T. W. (2020) · Journal of korean Academy of Child and Adolescent Psychiatry · doi:10.5765/jkacap.200013 · Cited by 7
Evaluation of metabolites levels in feces of patients with inflammatory bowel diseases
Zhgun, E. S., Kislun, Y. V., Калачнюк, Т. Н., Veselovsky, V. A., Urban, A., Tikhonova, P., Pavlenko, A. V., Ilchenko, G. N., & Ilina, E. N. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206603233 · Cited by 7
Guo, X., Zhu, Y.-L., Yang, L., Li, W., & Du, X.-F. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s385485 · Cited by 6
Cystic fibrosis and inflammatory bowel disease: parallels in gut physiology and microbiota
Barrack, K. E., & O’Toole, G. A. (2025) · Journal of Bacteriology · doi:10.1128/jb.00167-25 · Cited by 6
Bethlehem, L., Bartu, L., Marke, G., Mar, P., Feldman, S., Eggers, J., Ruprecht, C., Britton, G. J., Aggarwala, V., Bongers, G., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04442-2 · Cited by 6
Meeting update: faecal microbiota transplantation––bench, bedside, courtroom?
Ding, N. S., Mullish, B. H., McLaughlin, J. T., Hart, A. L., & Marchesi, J. R. (2016) · Frontline Gastroenterology · doi:10.1136/flgastro-2016-100752 · Cited by 6
Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges
Steube, A., Stallhofer, J., & Stallmach, A. (2023) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2023.1161610 · Cited by 6
Fäkaler Mikrobiota-Transfer (FMT) in Deutschland – Status und Perspektive
Stallmach, A., von Müller, L., Storr, M., Link, A., Konturek, P. C., Solbach, P. C., Weiss, K. H., Wahler, S., & Vehreschild, M. J. G. T. (2023) · Zeitschrift für Gastroenterologie · doi:10.1055/a-2075-2725 · Cited by 6
Zhang, J., Zhang, N., Dong, X.-T., Wang, X., Ma, H., Liu, Y., & Li, M.-R. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i21.4691 · Cited by 6
Ishikawa, D., Watanabe, H., Nomura, K., Zhang, X., Maruyama, T., Odakura, R., Koma, M., Shibuya, T., Osada, T., Fukuda, S., et al. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaf054 · Cited by 7
Lützhøft, D. O., Sánchez‐Alcoholado, L., Tougaard, P., Mentzel, C. M. J., Kot, W., Nielsen, D. S., & Hansen, A. K. (2019) · Research in Veterinary Science · doi:10.1016/j.rvsc.2019.09.009 · Cited by 6
Newman, K. M., & Vaughn, B. P. (2020) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.19.02610-2 · Cited by 6
Zhang, Y., Xue, X., Su, S., Zhou, H., Jin, Y., Shi, Y., Lin, J., Wang, J., Li, X., Yang, G., et al. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-3683 · Cited by 6
Singh, A., Mahajan, R., Kahlon, B. K., Dhaliwal, A. S., Midha, V., Mehta, V., Bansal, N., Singh, D., & Sood, A. (2022) · Indian Journal of Gastroenterology · doi:10.1007/s12664-022-01257-0 · Cited by 6
Manipulation of the intestinal microbiome-a slow journey to primetime
Kriger-Sharabi, O., Malnick, S. D. H., & Fisher, D. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i21.4975 · Cited by 6
Stallmach, A., Grunert, P., Pieper, D. H., & Steube, A. (2019) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0874-6603 · Cited by 6
A Summary of the Fifth Annual Virology Education HIV Microbiome Workshop
Sherrill-Mix, S. A., Connors, K. A., Aldrovandi, G. M., Brenchley, J. M., Boucher, C. A., Bushman, F. D., Collman, R. G., Dandekar, S., Klatt, N. R., Lagenaur, L. A., et al. (2020) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2020.0121 · Cited by 6
Long term management of ulcerative colitis with Faecal Microbiota Transplantation
Singh, A., Mahajan, R., Kao, D. H., Midha, V., & Sood, A. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100026 · Cited by 6
(2015) · United European Gastroenterology Journal · doi:10.1177/2050640615616068 · Cited by 6
Faecal transplantation for IBD management—pitfalls and promises
Quraishi, M. N., Critchlow, T., Bhala, N. B., Sharma, N., & Iqbal, T. H. (2017) · British Medical Bulletin · doi:10.1093/bmb/ldx040 · Cited by 6
The Gut Microbiome in Inflammatory Bowel Disease
Lavelle, A., & Sokol, H. (2019) · Springer eBooks · doi:10.1007/978-3-030-28703-0_16 · Cited by 6
Characteristics of Fecal Microbiota Transplantation Use in Inflammatory Bowel Disease Cohort
Bauer, C. M., Zhang, X., Long, M. D., & Sandler, R. S. (2020) · Crohn s & Colitis 360 · doi:10.1093/crocol/otaa024 · Cited by 6
Ding, X. L., Yang, X., & Wang, H. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100028 · Cited by 6
Role of Crosstalk Between Gut Microbiota and Immune Cells in Colorectal Cancer: A Narrative Review
Ye, M., Yuan, G., Jin, Y., & Zeng, X. (2025) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000172 · Cited by 5
Jia, J., Wu, Y., Liu, S., Chen, W., Li, R., Bai, Y., & Hu, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1593483 · Cited by 5
Raich, S. S., Majzoub, M. E., Haifer, C., Paramsothy, S., Shamim, M. M. I., Borody, T. J., Leong, R. W. L., & Kaakoush, N. O. (2025) · mSystems · doi:10.1128/msystems.00991-25 · Cited by 5
Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Where We Stand and What Is Next
Ishikawa, D., Zhang, X., Nomura, K., & Nagahara, A. (2025) · Inflammatory Intestinal Diseases · doi:10.1159/000549227 · Cited by 5
Nontraditional Treatment of Hepatic Encephalopathy
Singh, J., Ibrahim, B., & Han, S. B. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.01.007 · Cited by 5
Tayyib, H. M. U., Ali, A., Jabeen, S., Habib‐ur‐Rehman, Kamran, H., Bajaber, M. A., Usman, M., & Zhang, X. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03218-3 · Cited by 5
Quraishi, M. N., Moakes, C. A., Yalchin, M., Segal, J. P., Ives, N. J., Magill, L., Manzoor, S. E., Gerasimidis, K., Loi, S., McMullan, C., et al. (2024) · Efficacy and Mechanism Evaluation · doi:10.3310/ycjd4579 · Cited by 5
Hu, X., Ma, C., & Kong, X. (2024) · Cancer Screening and Prevention · doi:10.14218/csp.2024.00017 · Cited by 5
Saha, J., & Goswami, R. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10807-9 · Cited by 5
Trang, C., Kerdreux, E., Poinas, A., Planche, L., Sokol, H., Bémer, P., Cabanas, K., Hivernaud, E., Biron, L., Flet, L., et al. (2020) · Trials · doi:10.1186/s13063-020-04330-1 · Cited by 5
Evaluation of gut dysbiosis using serum and fecal bile acid profiles
Monma, T., Iwamoto, J., Ueda, H., Tamamushi, M., Kakizaki, F., Konishi, N., Yara, S., Miyazaki, T., Hirayama, T. T., Ikegami, T., et al. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i34.12484 · Cited by 5
Cytomegalovirus in donors for fecal microbiota transplantation, the phantom menace?
Galpérine, T., Engelmann, I., Hantz, S., Postil, D., Dewilde, A., Deplanque, D., Martin, R., Labreuche, J., Lazrek, M., Somers, S., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287847 · Cited by 5
Kasapoglu, M., Yadavalli, R., Nawaz, S., Althwanay, A. M., AlEdani, E. M., Kaur, H., & Butt, S. R. (2024) · Cureus · doi:10.7759/cureus.60786 · Cited by 5
Park, J., Hong, S. N., Lee, H. S., Shin, J., Oh, E. H., Nam, K., Seong, G., Kim, H. G., Kim, J. O., & Jeon, S. R. (2024) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2024.053 · Cited by 5
Treatment of Inflammatory Bowel Disease in Ulcerative Colitis
Chibbar, R., Alahmadi, A., & Dieleman, L. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804024-9.00037-9 · Cited by 5
Determinación de la microbiota intestinal en pacientes cirróticos de población mestizo-mexicana
Pérez‐Monter, C., Escalona-Nández, I., Estanes-Hernández, A., Noriega, L. G., & Torre-Delgadillo, A. (2018) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2018.02.010 · Cited by 5
Intestinal microbiota assessment in cirrhotic patients from a Mexican mestizo population
Pérez‐Monter, C., Escalona-Nández, I., Estanes-Hernández, A., Noriega, L. G., & Torre-Delgadillo, A. (2018) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2018.08.005 · Cited by 5
Holster, S., Repsilber, D., Geng, D., Hyötyläinen, T., Salonen, A., Lindqvist, C. M., Rajan, S., de Vos, W. M., Brummer, R. J., & König, J. (2020) · Beneficial Microbes · doi:10.3920/bm2020.0010 · Cited by 5
Metadata
- Authors
- Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., Zoetendal, E. G., D’Haens, G. R., & Ponsioen, C. Y.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Wageningen University & Research (NL)
- Corresponding author
- Ponsioen, Cyriel Y.
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 149
- Issue
- 1
- Pages
- 110-118.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1994882377
- Cited by
- 921
- References
- 29
- Citations by year
- 2026: 30 · 2025: 45 · 2024: 64 · 2023: 69 · 2022: 86 · 2021: 93 · 2020: 128 · 2019: 113 · 2018: 84 · 2017: 87 · 2016: 83 · 2015: 36
- FWCI
- 66.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- fecal microbiota transplantation, ulcerative colitis, clinical remission, endoscopic remission, Clostridium cluster XIVa, Clostridium cluster IV, gut microbiota composition, adverse events
- MeSH terms
- Adult, Aged, Biological Therapy, Colitis, Ulcerative, Double-Blind Method, Feces, Female, Humans, Intubation, Gastrointestinal, Male, Middle Aged, Remission Induction, Treatment Outcome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
